Float Short %

11.48

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

-0.06

EPS Last/This Y

0.92

EPS This/Next Y

0.89

Price

2.15

Target Price

4.91

Analyst Recom

2.33

Performance Q

-45.04

Relative Volume

1.25

Beta

2.15

Ticker: EDIT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	EDIT	2.43	0.09	0.17	50258
2025-12-10	EDIT	2.6	0.09	0.04	50223
2025-12-11	EDIT	2.55	0.09	0.29	50324
2025-12-12	EDIT	2.54	0.09	0.04	50316
2025-12-15	EDIT	2.44	0.09	0.12	50280
2025-12-16	EDIT	2.51	0.09	0.63	50241
2025-12-17	EDIT	2.38	0.09	0.05	50370
2025-12-18	EDIT	2.36	0.09	0.07	50420
2025-12-19	EDIT	2.34	0.09	0.03	50327
2025-12-22	EDIT	2.33	0.06	0.04	47728
2025-12-23	EDIT	2.18	0.06	3.08	47643
2025-12-26	EDIT	2.16	0.08	0.94	48302
2025-12-29	EDIT	2.1	0.08	2.30	48394
2025-12-30	EDIT	2.03	0.09	0.23	49043
2025-12-31	EDIT	2.06	0.09	0.05	49014
2026-01-02	EDIT	2.06	0.09	0.41	49095
2026-01-05	EDIT	2	0.09	1.24	49041
2026-01-06	EDIT	2.14	0.09	0.18	49216
2026-01-07	EDIT	2.15	0.10	1.10	49451
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	EDIT	2.44	60.9	-	-1.96
2025-12-10	EDIT	2.61	60.9	-	-1.96
2025-12-11	EDIT	2.55	60.9	-	-1.96
2025-12-12	EDIT	2.53	60.9	-	-1.96
2025-12-15	EDIT	2.44	60.9	-	-1.96
2025-12-16	EDIT	2.44	60.9	-	-1.96
2025-12-17	EDIT	2.37	60.9	-	-1.96
2025-12-18	EDIT	2.36	60.9	-	-1.96
2025-12-19	EDIT	2.35	60.9	-	-1.96
2025-12-22	EDIT	2.37	60.9	-	-1.96
2025-12-23	EDIT	2.18	60.9	-	-1.96
2025-12-26	EDIT	2.17	60.9	-	-1.96
2025-12-29	EDIT	2.10	60.9	-	-1.96
2025-12-30	EDIT	2.03	60.9	-	-1.96
2025-12-31	EDIT	2.06	60.9	-	-1.96
2026-01-02	EDIT	2.06	60.9	-	-1.96
2026-01-05	EDIT	2.00	60.9	-	-1.96
2026-01-06	EDIT	2.14	60.9	-	-1.96
2026-01-07	EDIT	2.15	60.9	-	-1.96
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	EDIT	-3.36	1.89	10.31
2025-12-10	EDIT	-3.36	1.89	10.89
2025-12-11	EDIT	-3.36	1.89	10.89
2025-12-12	EDIT	-3.42	1.89	10.89
2025-12-15	EDIT	-3.42	1.89	10.88
2025-12-16	EDIT	-3.74	1.89	10.88
2025-12-17	EDIT	-3.74	1.89	10.88
2025-12-18	EDIT	-3.74	1.89	10.88
2025-12-19	EDIT	-3.74	1.89	10.88
2025-12-22	EDIT	-3.74	1.91	10.88
2025-12-23	EDIT	-3.74	1.91	10.88
2025-12-26	EDIT	-3.74	1.91	11.48
2025-12-29	EDIT	-3.74	1.90	11.48
2025-12-30	EDIT	-3.74	1.90	11.48
2025-12-31	EDIT	-3.74	1.90	11.48
2026-01-02	EDIT	-3.74	1.90	11.48
2026-01-05	EDIT	-3.74	1.90	11.48
2026-01-06	EDIT	-3.74	1.90	11.48
2026-01-07	EDIT	-3.74	1.90	11.48
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.28

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.34

Insider Transactions

-3.74

Institutional Transactions

1.9

Beta

2.15

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.8

Max Drawdown 5-Year %

-98.9

Target Price

4.91

P/E

Forward P/E

PEG

P/S

4.55

P/B

14.97

P/Free Cash Flow

EPS

-2.38

Average EPS Est. Cur. Y

-1.96

EPS Next Y. (Est.)

-1.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-430.84

Relative Volume

1.25

Return on Equity vs Sector %

-1512.5

Return on Equity vs Industry %

-1497.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

Editas Medicine, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 246

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

stock quote shares EDIT – Editas Medicine, Inc. Stock Price stock today

news today EDIT – Editas Medicine, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EDIT – Editas Medicine, Inc. yahoo finance google finance

stock history EDIT – Editas Medicine, Inc. invest stock market

stock prices EDIT premarket after hours

ticker EDIT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EDIT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y